Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Bas C Mourik"'
Autor:
Louise Hendrikx, Colette L M van Hees, Jurriaan E M de Steenwinkel, Hannelore I Bax, Tom Sprong, Bert Mulder, Arjan Jansz, Arjanne van Griethuysen, Ron Bosboom, Annette Stemerding, Marjolein Koetsier, Marco van Coevorden, Bas C Mourik, Koen D Quint, Alewijn Ott, Dick van Soolingen, Saskia Kuipers, Reinout van Crevel, Jakko van Ingen
Publikováno v:
Open Forum Infectious Diseases, 9, 4
Open Forum Infectious Diseases, 9(4):ofac077. Oxford University Press
Open Forum Infectious Diseases, 9(4). OXFORD UNIV PRESS INC
Open Forum Infectious Diseases, 9
Open Forum Infectious Diseases, 9(4):ofac077. Oxford University Press
Open Forum Infectious Diseases, 9(4). OXFORD UNIV PRESS INC
Open Forum Infectious Diseases, 9
Background Mycobacterium marinum is a nontuberculous mycobacterium that causes skin and soft tissue infections. Treatment consists of multiple antibiotics, sometimes combined with surgical debridement. There is little evidence for the choice of antib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d316e4978a7a93aa4f88f193360c250
Autor:
Mario J.A.W.M. van Bussel, Els Wessels, Stefan A. Boers, Eric C. J. Claas, Caroline S. de Brouwer, Bas C. Mourik
Publikováno v:
Journal of Virological Methods, 298. ELSEVIER
Journal of Virological Methods
Journal of Virological Methods
At the time SARS-CoV-2 was identified as the cause of coronavirus disease 2019 (COVID-19) no in vitro diagnostic (IVD) tests were available since it was a new virus. Very shortly after the release of the genomic sequence of SARS-CoV-2, laboratory-dev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76589a156049a266e49eb8a8273bfea0
https://hdl.handle.net/1887/3230200
https://hdl.handle.net/1887/3230200
Autor:
Louise, Hendrikx, Colette L M, van Hees, Jurriaan E M, de Steenwinkel, Hannelore I, Bax, Tom, Sprong, Bert, Mulder, Arjan, Jansz, Arjanne, van Griethuysen, Ron, Bosboom, Annette, Stemerding, Marjolein, Koetsier, Marco, van Coevorden, Bas C, Mourik, Koen D, Quint, Alewijn, Ott, Dick, van Soolingen, Saskia, Kuipers, Reinout, van Crevel, Jakko, van Ingen
Publikováno v:
Open forum infectious diseases. 9(4)
We performed a retrospective cohort study of culture-confirmedForty cases ofProlonged and susceptibility-guided treatment results in a 90% cure rate in
Autor:
Gerjo J. de Knegt, Tom H. M. Ottenhoff, Annelies Verbon, Bas C. Mourik, Ruth Huizinga, Pieter J. M. Leenen, Jurriaan E. M. de Steenwinkel, Dick van Soolingen
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-11 (2019)
Scientific Reports, 9. NATURE PUBLISHING GROUP
Scientific Reports, 9:19922. Nature Publishing Group
Scientific Reports
Scientific Reports, 9. NATURE PUBLISHING GROUP
Scientific Reports, 9:19922. Nature Publishing Group
Scientific Reports
Substantial differences exist in virulence among Mycobacterium tuberculosis strains in preclinical TB models. In this study we show how virulence affects host responses in mice during the first four weeks of infection with a mycobacterial strain belo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae2d580cdde0c0be798b565db3c97084
https://hdl.handle.net/1887/121990
https://hdl.handle.net/1887/121990
Autor:
Hannelore I. Bax, Gerjo J. de Knegt, Jurriaan E. M. de Steenwinkel, Bas C. Mourik, Ulrika S. H. Simonsson, Annelies Verbon, Robin J. Svensson
Publikováno v:
Scientific Reports, 8:5714. Nature Publishing Group
Scientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
Scientific Reports
Preclinical treatment outcome evaluation of tuberculosis (TB) occurs primarily in mice. Current designs compare relapse rates of different regimens at selected time points, but lack information about the correlation between treatment length and treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cca5be3d502cc31a21085dd20db0d913
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-352487
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-352487
Autor:
Pieter J. M. Leenen, Jurriaan E. M. de Steenwinkel, Bas C. Mourik, E Lubberts, Tom H. M. Ottenhoff
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, 8
Frontiers in Immunology, 8:294. Frontiers Media S.A.
Frontiers in Immunology, 8
Frontiers in Immunology, 8:294. Frontiers Media S.A.
The classical paradigm of tuberculosis (TB) immunity, with a central protective role for Th1 responses and IFN-γ-stimulated cellular responses, has been challenged by unsatisfactory results of vaccine strategies aimed at enhancing Th1 immunity. More
Autor:
Bas C. Mourik, Hannelore I. Bax, Jurriaan E. M. de Steenwinkel, Gerjo J. de Knegt, Johan W. Mouton, Annelies Verbon
Publikováno v:
Antimicrobial Agents & Chemotherapy, 61(10):e00696-17. American Society for Microbiology
Mycobacterium tuberculosis Beijing strains are associated with lower treatment success rates in tuberculosis (TB) patients. In contrast, laboratory strains such as H37Rv are often used in preclinical tuberculosis models. Therefore, we explored the im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::198f8855462795e4ec623ab30581289e
https://pure.eur.nl/en/publications/92f3113a-0139-48be-9199-0c463a466739
https://pure.eur.nl/en/publications/92f3113a-0139-48be-9199-0c463a466739
Autor:
Irma A. J. M. Bakker-Woudenberg, Ruth Huizinga, Jinshan Wang, Bram C. J. van der Eerden, Jurriaan E. M. de Steenwinkel, Bas C. Mourik, Gerjo J. de Knegt, Pieter J. M. Leenen, Charles R. Krois, Joseph L. Napoli
Publikováno v:
American Journal of Respiratory Cell and Molecular Biology, 56(2), 233-241. American Thoracic Society
Immune-modulating drugs that target myeloid-derived suppressor cells or stimulate natural killer T cells have been shown to reduce mycobacterial loads in tuberculosis (TB). We aimed to determine if a combination of these drugs as adjunct immunotherap